Budesonide
- Product NDC
- 0591-2510
- 11-digit product format
- 005912510
- Labeler code
- 0591
- Product ID
- 0591-2510_5b1c0fe2-b58d-43b4-8784-038653663c44
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Budesonide
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA205457
- Marketing category
- ANDA
- Marketing start
- 2018-07-05
- Substance
- BUDESONIDE
- Active strength
- 9 mg/1
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Budesonide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUDESONIDE | 9 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | Q3OKS62Q6X |
| Rxcui | 1366550 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0591-2510-30 | Budesonide | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | | 21 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0591-2510 | BUDESONIDE TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 19 | Current NDC, Legacy NDC, 1 package rows | 20240823_41d4fd39-81ee-41be-b34d-efb12b3a359d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0591-2510-30 | 00591251030 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0591-2510-30) | 2018-07-05 | 0000-00-00 | No | No | Current |